High- and low-risk prostate cancer treated with 3D CT-guided brachytherapy: 1- to 5-year follow-up

Journal of Endourology

Volumn 14, Issue 4, 2000, Pages 357-366

  Koutrouvelis, Panos ^a,b   Lailas, Niko ^a   Katz, Stuart ^a   Goldson, Alfred ^a,b   Gilmontero, Guillermo ^a   Bondy, Harold ^a   Hendricks, Fred ^a   Sehn, James T ^a   Schwartz, David ^a   Khawand, Nabil ^a   Willis, Arnold ^a   Gillenwater, Jay Y ^c  

^a Uro Radiology Prostate Institute   (United States)

^b HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 125; PALLADIUM; PROSTATE SPECIFIC ANTIGEN;

ARTICLE; BRACHYTHERAPY; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; FOLLOW UP; HIGH RISK POPULATION; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CARCINOMA; RECTUM ULCER; THREE DIMENSIONAL IMAGING; TREATMENT OUTCOME;

EID: 0033947263     PISSN: 08927790     EISSN: None     Source Type: Journal    
DOI: 10.1089/end.2000.14.357     Document Type: Article

References (10)

1. Kaplan ID, Cox RS, Bagshaw MA. Prostate specific antigen after external beam radiotherapy for prostatic cancer: Follow-up. J Urol 1993;149:519-522.
2. Stamey TA, Kabalin JN, Ferrari M. Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate III: Radiation treated patients. J Urol 1989;141:1084-1087.
3. Lee WR, Hanlon AL, Hanks GE. Prostate specific antigen nadir following external beam radiation therapy for clinically localized prostate cancer: The relationship between nadir level and disease-free survival. J Urol 1996;156:450-453.
4. Hanks GE, Martz KL, Krall JM, et al. Analysis of independent variables affecting survival after recurrence of prostate cancer. Int J Radiat Oncol Biol Phys 1989;16:1431-1435.
5. Lai PP, Perez CA, Lockett MA. Prognostic significance of pelvic recurrence and distant metastasis in prostate carcinoma following definitive radiotherapy. Int J Radiat Oncol Biol Phys 1992;24:423-430.
6. Holzman M, Carlton C, Scardino PT. The frequency and morbidity of local tumor recurrence after definitive radiotherapy for state C prostate cancer. J Urol 1991;146:1578-1582.
7. Nag S, Baird M, Blasko J, et al. American Brachytherapy Society Survey of Current Clinical Practice for Permanent Brachytherapy of Prostate Cancer. J Brachyther Int 1997:13:243-251.
8. Ragde H, Blasko J, Grimm P, et al. Interstitial iodine-125 radiation without adjuvant therapy in the treatment of clinically localized prostate carcinoma. Cancer 1997;80:442-453.
9. Koutrouvelis PG. Three-dimensional stereotactic posterior ischiorectal space computerized tomography guided brachytherapy of prostate cancer: A preliminary report. J Urol 1998;159:142-145.
10. Moerland MA. The effect of edema on postimplant dosimetry of permanent iodine-125 prostate implants: A simulation study. J Brachyther Int 1998;14:225-231.